131
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

An overview of candesartan in clinical practice

&
Pages 975-982 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amedeo Mugellini & Valentina Nieswandt. (2012) Candesartan plus hydrochlorothiazide: an overview of its use and efficacy. Expert Opinion on Pharmacotherapy 13:18, pages 2699-2709.
Read now

Articles from other publishers (7)

Diyar Salahuddin Ali. (2023) Chemometric Methods for Simultaneous Determination of Candesartan Cilexetil and Hydrochlorothiazide in Binary Combinations. Journal of Analytical Methods in Chemistry 2023, pages 1-14.
Crossref
Nathalia Buitrago-Gómez, Natalia Campo-Rivera, Lunevar Figueroa-Torregroza & María Eugenia Casanova-Valderrama. (2022) Hipertensión arterial esencial: ¿cuál agente antihipertensivo elegir?. Salud UIS 54:1.
Crossref
Steeva Sunny, Stephy Elza John & Nagula Shankaraiah. (2021) Exploration of C‐H Activation Strategies in Construction of Functionalized 2‐Aryl Benzoazoles: A Decisive Review. Asian Journal of Organic Chemistry 10:8, pages 1986-2009.
Crossref
Mari Sakamoto, Masanori Asakura, Atsushi Nakano, Hideaki Kanzaki, Yasuo Sugano, Makoto Amaki, Takahiro Ohara, Takuya Hasegawa, Toshihisa Anzai & Masafumi Kitakaze. (2015) Azilsartan, but not Candesartan Improves Left Ventricular Diastolic Function in Patients with Hypertension and Heart Failure. International Journal of Gerontology 9:4, pages 201-205.
Crossref
Jeffrey Olearczyk, Sheng Gao, Marianne Eybye, Satyasri Yendluri, Lori Andrews, Steven Bartz, Doris Cully & Marija Tadin-Strapps. (2013) Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension. Hypertension Research 37:5, pages 405-412.
Crossref
Peter Bramlage, Hartmut Buhck & Claudia Zemmrich. (2014) Candesartan Cilexetil 32 mg/Hydrochlorothiazide 25 mg in Unselected Patients with High or Very High Cardiovascular Risk: Efficacy, Safety, and Metabolic Impact. Clinical Drug Investigation 34:4, pages 241-249.
Crossref
Jan Józef Braszko, Dominik Wincewicz & Piotr Jakubów. (2012) Candesartan prevents impairment of recall caused by repeated stress in rats. Psychopharmacology 225:2, pages 421-428.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.